The federal Mirena multidistrict litigation (MDL) before Judge Cathy Seibel in the Southern District of New York has reached a pivotal stage with the August selection of 12 so-called bellwether lawsuits. With the purpose of eliminating redundancies in the discovery process, preventing conflicting pretrial rulings... Read More

With the scope and volume of testosterone drug lawsuits continuing to increase at a rapid pace, new motions have been filed by plaintiffs seeking consolidation of cases alleging negligence on the part of drug makers. Recent weeks have seen two significant motions from plaintiffs that... Read More

With the Pradaxa multidistrict litigation (MDL) reaching critical stages in the coming months, the pace of developments in the cases pending under the auspices of Judge David R. Herndon in the U.S. District Court for the Southern District of Illinois shows no signs of abating.... Read More

As the wave of Mirena IUD lawsuits continues to make its way through the judicial system across the country, a recent case management order issued in the Mirena Multidistrict Litigation (MDL) promises to slow the progress of possible settlement of many such cases, at least... Read More

Increased skepticism and closer scrutiny of the benefits and risks of testosterone therapy is beginning to emerge in the wake of several research reports highlighting their potential danger, according to a recent New York Times story by Roni Caryn Rabin. However, given the wild popularity these... Read More

In the midst of growing concern about the safety of widely popular testosterone therapy drugs, consumer advocacy watchdog group Public Citizen has just petitioned the U.S. Food and Drug Administration to place bold, stark labeling on such medications alerting users to the increased risk of... Read More

In response to two recent studies of the possible connection between testosterone therapy and an increased risk of heart attack, stroke and death, the U.S. Food and Drug Administration (FDA) has announced that it will conduct a formal assessment and report on its conclusions and... Read More

Doctors in the United Kingdom have recently been ordered to explicitly advise patients of the blood clot risks involved in taking popular oral contraceptives Yaz and Yasmin. Both brand name birth control pills are manufactured by German pharmaceutical company Bayer. Specifically, general practitioners throughout Britain... Read More